Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lassa Fever | 23 | 2024 | 97 | 6.050 |
Why?
|
Genome, Viral | 29 | 2024 | 674 | 5.650 |
Why?
|
Lassa virus | 22 | 2024 | 99 | 4.890 |
Why?
|
Ebolavirus | 28 | 2023 | 250 | 4.790 |
Why?
|
Hemorrhagic Fever, Ebola | 30 | 2023 | 424 | 4.300 |
Why?
|
Selection, Genetic | 30 | 2014 | 877 | 3.010 |
Why?
|
Viruses | 7 | 2023 | 373 | 2.440 |
Why?
|
Disease Outbreaks | 24 | 2023 | 1761 | 2.040 |
Why?
|
Metagenomics | 7 | 2023 | 474 | 1.860 |
Why?
|
RNA, Viral | 23 | 2024 | 2874 | 1.800 |
Why?
|
Evolution, Molecular | 20 | 2024 | 1896 | 1.710 |
Why?
|
Metagenome | 7 | 2021 | 465 | 1.540 |
Why?
|
Biological Evolution | 14 | 2021 | 1076 | 1.530 |
Why?
|
High-Throughput Nucleotide Sequencing | 11 | 2024 | 3670 | 1.430 |
Why?
|
Phylogeny | 24 | 2023 | 2843 | 1.370 |
Why?
|
Genome, Human | 18 | 2024 | 4446 | 1.350 |
Why?
|
Capsid | 2 | 2022 | 435 | 1.310 |
Why?
|
Genetic Variation | 30 | 2022 | 6610 | 1.170 |
Why?
|
Babesia microti | 2 | 2019 | 31 | 1.160 |
Why?
|
Plasmodium falciparum | 19 | 2020 | 1741 | 1.150 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2023 | 1361 | 1.130 |
Why?
|
RNA Viruses | 3 | 2019 | 112 | 1.130 |
Why?
|
DNA Barcoding, Taxonomic | 4 | 2019 | 134 | 1.090 |
Why?
|
Contact Tracing | 4 | 2022 | 275 | 1.090 |
Why?
|
Babesiosis | 2 | 2019 | 92 | 1.080 |
Why?
|
Epitopes, T-Lymphocyte | 5 | 2023 | 827 | 1.030 |
Why?
|
Nucleic Acids | 3 | 2023 | 189 | 0.990 |
Why?
|
Open Reading Frames | 3 | 2021 | 818 | 0.980 |
Why?
|
Isovaleryl-CoA Dehydrogenase | 1 | 2024 | 5 | 0.920 |
Why?
|
Hemorrhagic Fevers, Viral | 4 | 2023 | 23 | 0.900 |
Why?
|
Genetic Techniques | 4 | 2016 | 428 | 0.880 |
Why?
|
Sierra Leone | 15 | 2021 | 171 | 0.840 |
Why?
|
Meningitis | 2 | 2021 | 219 | 0.830 |
Why?
|
Polymorphism, Single Nucleotide | 38 | 2021 | 16044 | 0.820 |
Why?
|
Virus Diseases | 3 | 2020 | 724 | 0.820 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2024 | 173 | 0.810 |
Why?
|
Haplotypes | 25 | 2020 | 2722 | 0.810 |
Why?
|
Dengue Virus | 3 | 2021 | 204 | 0.800 |
Why?
|
Genomics | 17 | 2024 | 5926 | 0.780 |
Why?
|
Antibodies, Viral | 17 | 2022 | 3214 | 0.780 |
Why?
|
Nigeria | 20 | 2023 | 781 | 0.770 |
Why?
|
Macaca | 2 | 2022 | 413 | 0.770 |
Why?
|
Communicable Diseases, Emerging | 2 | 2014 | 148 | 0.770 |
Why?
|
Genome, Protozoan | 5 | 2016 | 153 | 0.760 |
Why?
|
Edar Receptor | 4 | 2016 | 24 | 0.750 |
Why?
|
Diagnostic Test Approval | 1 | 2021 | 3 | 0.750 |
Why?
|
Africa, Western | 13 | 2023 | 160 | 0.750 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2021 | 40 | 0.740 |
Why?
|
Encephalitis | 2 | 2021 | 441 | 0.710 |
Why?
|
Nucleocapsid Proteins | 2 | 2020 | 75 | 0.710 |
Why?
|
Directed Molecular Evolution | 1 | 2021 | 165 | 0.700 |
Why?
|
Mumps virus | 1 | 2020 | 23 | 0.700 |
Why?
|
DNA, Protozoan | 5 | 2015 | 227 | 0.690 |
Why?
|
Software | 7 | 2024 | 4480 | 0.680 |
Why?
|
Virus Release | 1 | 2020 | 35 | 0.680 |
Why?
|
Dependovirus | 2 | 2022 | 720 | 0.670 |
Why?
|
Dengue | 3 | 2021 | 258 | 0.650 |
Why?
|
3' Untranslated Regions | 1 | 2021 | 515 | 0.650 |
Why?
|
Mumps | 1 | 2020 | 71 | 0.650 |
Why?
|
Malaria, Falciparum | 8 | 2020 | 1077 | 0.640 |
Why?
|
Polymerase Chain Reaction | 8 | 2021 | 6082 | 0.620 |
Why?
|
Genes, Reporter | 4 | 2024 | 1524 | 0.620 |
Why?
|
Humans | 186 | 2024 | 768171 | 0.600 |
Why?
|
Disease | 2 | 2021 | 675 | 0.590 |
Why?
|
Epidemiology | 1 | 2020 | 278 | 0.590 |
Why?
|
Encephalitis, Tick-Borne | 1 | 2018 | 45 | 0.570 |
Why?
|
RNA Stability | 1 | 2019 | 320 | 0.570 |
Why?
|
Enzyme Assays | 1 | 2018 | 103 | 0.570 |
Why?
|
Encephalitis Viruses, Tick-Borne | 1 | 2018 | 48 | 0.570 |
Why?
|
Computer-Assisted Instruction | 1 | 2020 | 366 | 0.560 |
Why?
|
Laboratories | 1 | 2021 | 463 | 0.560 |
Why?
|
Molecular Epidemiology | 7 | 2021 | 473 | 0.560 |
Why?
|
Alleles | 16 | 2021 | 6894 | 0.540 |
Why?
|
Fungi | 1 | 2019 | 345 | 0.540 |
Why?
|
Genetics, Population | 13 | 2014 | 944 | 0.540 |
Why?
|
Genome-Wide Association Study | 10 | 2024 | 12795 | 0.530 |
Why?
|
Microfluidic Analytical Techniques | 2 | 2020 | 820 | 0.530 |
Why?
|
Sequence Analysis, RNA | 7 | 2020 | 2040 | 0.530 |
Why?
|
Gene Transfer Techniques | 1 | 2021 | 1207 | 0.530 |
Why?
|
Gene Targeting | 1 | 2019 | 841 | 0.520 |
Why?
|
Endonucleases | 2 | 2018 | 371 | 0.510 |
Why?
|
Hair | 3 | 2016 | 508 | 0.510 |
Why?
|
Peptides | 3 | 2023 | 4354 | 0.500 |
Why?
|
RNA, Protozoan | 1 | 2015 | 46 | 0.500 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3115 | 0.470 |
Why?
|
Zoonoses | 4 | 2023 | 180 | 0.470 |
Why?
|
Gene Frequency | 21 | 2016 | 3623 | 0.470 |
Why?
|
Information Theory | 1 | 2014 | 49 | 0.460 |
Why?
|
Sequence Analysis, DNA | 16 | 2020 | 4786 | 0.460 |
Why?
|
Mutation | 23 | 2023 | 30237 | 0.440 |
Why?
|
Public Health | 4 | 2023 | 2679 | 0.440 |
Why?
|
Amino Acids | 1 | 2020 | 1716 | 0.440 |
Why?
|
Antigens, Viral | 9 | 2021 | 995 | 0.430 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 3238 | 0.430 |
Why?
|
Exocrine Glands | 1 | 2013 | 46 | 0.430 |
Why?
|
Data Interpretation, Statistical | 2 | 2014 | 2709 | 0.420 |
Why?
|
Plasmodium vivax | 1 | 2015 | 203 | 0.420 |
Why?
|
Computer Simulation | 7 | 2024 | 6283 | 0.420 |
Why?
|
Malaria, Vivax | 1 | 2015 | 168 | 0.420 |
Why?
|
Bacteria | 3 | 2019 | 2216 | 0.420 |
Why?
|
Benchmarking | 1 | 2019 | 1057 | 0.410 |
Why?
|
Gonorrhea | 3 | 2024 | 355 | 0.410 |
Why?
|
N-Acetylglucosaminyltransferases | 2 | 2021 | 167 | 0.400 |
Why?
|
Antimalarials | 3 | 2020 | 909 | 0.400 |
Why?
|
HEK293 Cells | 5 | 2021 | 4280 | 0.390 |
Why?
|
Single-Cell Analysis | 3 | 2021 | 2540 | 0.390 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 2024 | 792 | 0.390 |
Why?
|
Access to Information | 1 | 2015 | 317 | 0.390 |
Why?
|
Genetic Diseases, Inborn | 2 | 2016 | 606 | 0.380 |
Why?
|
Animals | 48 | 2024 | 169285 | 0.380 |
Why?
|
Visual Cortex | 1 | 2019 | 1094 | 0.380 |
Why?
|
Cholera | 3 | 2013 | 754 | 0.380 |
Why?
|
Gene Expression Regulation | 8 | 2024 | 11930 | 0.380 |
Why?
|
Encephalitis Virus, California | 2 | 2020 | 9 | 0.370 |
Why?
|
Proteome | 1 | 2021 | 1890 | 0.370 |
Why?
|
Drug Resistance | 4 | 2020 | 1599 | 0.350 |
Why?
|
Linkage Disequilibrium | 14 | 2013 | 1997 | 0.350 |
Why?
|
Bioethics | 1 | 2012 | 118 | 0.350 |
Why?
|
Culicidae | 3 | 2020 | 111 | 0.350 |
Why?
|
Primates | 3 | 2022 | 520 | 0.330 |
Why?
|
Malaria | 5 | 2024 | 1249 | 0.330 |
Why?
|
Genetic Loci | 5 | 2020 | 2629 | 0.320 |
Why?
|
Neisseria gonorrhoeae | 3 | 2024 | 249 | 0.320 |
Why?
|
Seroepidemiologic Studies | 3 | 2024 | 404 | 0.320 |
Why?
|
Nucleic Acid Amplification Techniques | 2 | 2024 | 340 | 0.320 |
Why?
|
HLA Antigens | 4 | 2023 | 1334 | 0.320 |
Why?
|
Respiratory Syncytial Virus Infections | 2 | 2024 | 365 | 0.310 |
Why?
|
Transgenes | 2 | 2022 | 1016 | 0.310 |
Why?
|
Death | 1 | 2013 | 683 | 0.300 |
Why?
|
Health Policy | 1 | 2021 | 2697 | 0.300 |
Why?
|
Virion | 3 | 2020 | 429 | 0.300 |
Why?
|
Quantitative Trait Loci | 6 | 2021 | 2131 | 0.300 |
Why?
|
Recombination, Genetic | 7 | 2021 | 1525 | 0.300 |
Why?
|
Genotype | 18 | 2023 | 13045 | 0.300 |
Why?
|
Statistics as Topic | 1 | 2014 | 2357 | 0.300 |
Why?
|
Bacterial Proteins | 2 | 2018 | 3840 | 0.290 |
Why?
|
Amino Acid Sequence | 8 | 2024 | 13422 | 0.290 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1514 | 0.290 |
Why?
|
Filoviridae | 2 | 2019 | 15 | 0.290 |
Why?
|
Genome, Bacterial | 1 | 2012 | 796 | 0.280 |
Why?
|
Molecular Diagnostic Techniques | 4 | 2024 | 620 | 0.280 |
Why?
|
Plasmodium | 2 | 2024 | 248 | 0.280 |
Why?
|
Species Specificity | 6 | 2021 | 2415 | 0.280 |
Why?
|
Interleukins | 1 | 2012 | 796 | 0.280 |
Why?
|
Eccrine Glands | 2 | 2018 | 52 | 0.280 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2023 | 4648 | 0.270 |
Why?
|
CD40 Ligand | 3 | 2003 | 528 | 0.270 |
Why?
|
Africa | 6 | 2022 | 725 | 0.270 |
Why?
|
Information Dissemination | 1 | 2015 | 1143 | 0.270 |
Why?
|
Computational Biology | 5 | 2019 | 3567 | 0.270 |
Why?
|
Base Sequence | 11 | 2015 | 12422 | 0.270 |
Why?
|
Models, Animal | 1 | 2013 | 2122 | 0.260 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4978 | 0.260 |
Why?
|
Pyruvate Kinase | 1 | 2008 | 191 | 0.260 |
Why?
|
Viral Envelope Proteins | 3 | 2020 | 640 | 0.260 |
Why?
|
Models, Genetic | 9 | 2021 | 3447 | 0.260 |
Why?
|
Pandemics | 8 | 2022 | 8747 | 0.260 |
Why?
|
Disease Reservoirs | 3 | 2018 | 123 | 0.260 |
Why?
|
Fever | 4 | 2024 | 1614 | 0.250 |
Why?
|
Disaster Planning | 2 | 2022 | 559 | 0.250 |
Why?
|
Brain | 5 | 2023 | 27362 | 0.250 |
Why?
|
Influenza, Human | 3 | 2024 | 1541 | 0.250 |
Why?
|
Biomedical Research | 3 | 2016 | 3463 | 0.250 |
Why?
|
Blood | 3 | 2018 | 599 | 0.250 |
Why?
|
Gene Expression | 5 | 2024 | 7601 | 0.250 |
Why?
|
Hair Follicle | 2 | 2018 | 219 | 0.240 |
Why?
|
Nucleoproteins | 3 | 2020 | 110 | 0.240 |
Why?
|
Gene Expression Profiling | 3 | 2020 | 9540 | 0.240 |
Why?
|
Immunoassay | 4 | 2018 | 746 | 0.230 |
Why?
|
Sequence Deletion | 3 | 2023 | 1497 | 0.230 |
Why?
|
Male | 54 | 2024 | 364731 | 0.230 |
Why?
|
Macaca mulatta | 5 | 2023 | 2363 | 0.220 |
Why?
|
Databases, Nucleic Acid | 2 | 2015 | 204 | 0.220 |
Why?
|
Borrelia | 1 | 2024 | 66 | 0.220 |
Why?
|
Guinea | 4 | 2016 | 33 | 0.220 |
Why?
|
Vocalization, Animal | 1 | 2024 | 95 | 0.220 |
Why?
|
Viral Proteins | 4 | 2020 | 1802 | 0.220 |
Why?
|
Histocompatibility Antigens | 2 | 2023 | 479 | 0.220 |
Why?
|
Mice | 10 | 2024 | 82049 | 0.220 |
Why?
|
Receptors, CCR5 | 1 | 2005 | 491 | 0.220 |
Why?
|
Cells | 1 | 2024 | 166 | 0.210 |
Why?
|
Metabolic Diseases | 3 | 2020 | 684 | 0.210 |
Why?
|
Mental Disorders | 1 | 2023 | 6873 | 0.210 |
Why?
|
Genetic Markers | 4 | 2019 | 2603 | 0.210 |
Why?
|
Immunity, Innate | 5 | 2022 | 3080 | 0.210 |
Why?
|
Female | 53 | 2024 | 397187 | 0.200 |
Why?
|
Pan troglodytes | 2 | 2018 | 224 | 0.200 |
Why?
|
Epidemics | 3 | 2018 | 517 | 0.200 |
Why?
|
Amino Acid Substitution | 3 | 2016 | 1743 | 0.200 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2023 | 168 | 0.200 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2024 | 149 | 0.190 |
Why?
|
Chromosome Mapping | 6 | 2015 | 4620 | 0.190 |
Why?
|
Polyribosomes | 1 | 2021 | 109 | 0.190 |
Why?
|
Borrelia burgdorferi | 1 | 2023 | 183 | 0.190 |
Why?
|
Oxidoreductases | 1 | 2024 | 410 | 0.190 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2021 | 69 | 0.190 |
Why?
|
Ochlerotatus | 1 | 2020 | 4 | 0.190 |
Why?
|
Sequence Analysis | 1 | 2021 | 240 | 0.180 |
Why?
|
Encephalitis, California | 1 | 2020 | 6 | 0.180 |
Why?
|
Genetic Fitness | 1 | 2022 | 120 | 0.180 |
Why?
|
Polymorphism, Genetic | 8 | 2021 | 4249 | 0.180 |
Why?
|
Sequence Alignment | 3 | 2015 | 2179 | 0.180 |
Why?
|
Molecular Sequence Data | 14 | 2015 | 17623 | 0.180 |
Why?
|
Adaptation, Physiological | 4 | 2018 | 1312 | 0.180 |
Why?
|
Conserved Sequence | 3 | 2023 | 1162 | 0.180 |
Why?
|
Basic Reproduction Number | 1 | 2020 | 38 | 0.180 |
Why?
|
Drug Resistance, Viral | 3 | 2023 | 869 | 0.180 |
Why?
|
Myopathies, Structural, Congenital | 1 | 2021 | 104 | 0.180 |
Why?
|
Influenza A virus | 2 | 2024 | 460 | 0.180 |
Why?
|
Young Adult | 20 | 2024 | 60066 | 0.170 |
Why?
|
Universities | 2 | 2023 | 1005 | 0.170 |
Why?
|
Senegal | 5 | 2024 | 256 | 0.170 |
Why?
|
Phylogeography | 3 | 2018 | 72 | 0.170 |
Why?
|
Mammals | 2 | 2023 | 1135 | 0.170 |
Why?
|
Iran | 1 | 2023 | 763 | 0.170 |
Why?
|
Gene Library | 3 | 2019 | 1064 | 0.170 |
Why?
|
Vaccination | 3 | 2021 | 3437 | 0.170 |
Why?
|
Autopsy | 2 | 2021 | 1011 | 0.170 |
Why?
|
Laboratories, Hospital | 1 | 2021 | 192 | 0.170 |
Why?
|
Filoviridae Infections | 1 | 2019 | 6 | 0.170 |
Why?
|
Yellow Fever | 1 | 2020 | 54 | 0.160 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2023 | 3610 | 0.160 |
Why?
|
Virus Assembly | 1 | 2020 | 141 | 0.160 |
Why?
|
Macaca fascicularis | 1 | 2021 | 912 | 0.160 |
Why?
|
Ciprofloxacin | 3 | 2023 | 313 | 0.160 |
Why?
|
Middle Aged | 26 | 2024 | 223487 | 0.160 |
Why?
|
United States | 14 | 2024 | 73039 | 0.160 |
Why?
|
Terrorism | 1 | 2022 | 211 | 0.160 |
Why?
|
Population Groups | 2 | 2010 | 209 | 0.160 |
Why?
|
Sensitivity and Specificity | 5 | 2024 | 14729 | 0.160 |
Why?
|
International Cooperation | 3 | 2016 | 1436 | 0.160 |
Why?
|
Motor Neurons | 1 | 2024 | 870 | 0.160 |
Why?
|
Genetic Engineering | 1 | 2024 | 936 | 0.160 |
Why?
|
Artemisinins | 1 | 2020 | 217 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 11 | 2017 | 18065 | 0.160 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2021 | 271 | 0.150 |
Why?
|
Vero Cells | 1 | 2019 | 485 | 0.150 |
Why?
|
DNA Primers | 2 | 2021 | 2828 | 0.150 |
Why?
|
Virology | 2 | 2016 | 76 | 0.150 |
Why?
|
Computer Systems | 1 | 2020 | 469 | 0.150 |
Why?
|
Limit of Detection | 1 | 2019 | 277 | 0.150 |
Why?
|
RNA Ligase (ATP) | 1 | 1997 | 9 | 0.150 |
Why?
|
Adult | 28 | 2024 | 223646 | 0.150 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2021 | 553 | 0.150 |
Why?
|
Genome | 5 | 2024 | 1754 | 0.150 |
Why?
|
RNA, Catalytic | 1 | 1997 | 52 | 0.140 |
Why?
|
Honduras | 1 | 2017 | 39 | 0.140 |
Why?
|
Prevalence | 7 | 2022 | 15869 | 0.140 |
Why?
|
Lyme Disease | 1 | 2023 | 630 | 0.140 |
Why?
|
HIV | 2 | 2020 | 1597 | 0.140 |
Why?
|
Enhancer Elements, Genetic | 1 | 2024 | 1367 | 0.140 |
Why?
|
Financing, Government | 1 | 2021 | 473 | 0.140 |
Why?
|
DNA, Bacterial | 2 | 2024 | 1478 | 0.140 |
Why?
|
MicroRNAs | 3 | 2020 | 3803 | 0.140 |
Why?
|
Algorithms | 5 | 2021 | 14164 | 0.140 |
Why?
|
Integrins | 1 | 2021 | 842 | 0.140 |
Why?
|
Phenotype | 9 | 2021 | 16726 | 0.140 |
Why?
|
South America | 2 | 2015 | 180 | 0.140 |
Why?
|
Antibodies, Neutralizing | 4 | 2022 | 2009 | 0.140 |
Why?
|
Atovaquone | 1 | 2016 | 56 | 0.130 |
Why?
|
Cytochromes b | 1 | 2016 | 35 | 0.130 |
Why?
|
Research Support as Topic | 1 | 2021 | 696 | 0.130 |
Why?
|
Microvessels | 1 | 2021 | 585 | 0.130 |
Why?
|
Ribonucleases | 1 | 2017 | 266 | 0.130 |
Why?
|
Government Regulation | 1 | 2021 | 525 | 0.130 |
Why?
|
Protein Multimerization | 1 | 2021 | 966 | 0.130 |
Why?
|
Motor Cortex | 1 | 2024 | 1013 | 0.130 |
Why?
|
Nucleic Acid Hybridization | 1 | 2018 | 1305 | 0.130 |
Why?
|
Colombia | 1 | 2017 | 287 | 0.130 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2021 | 2521 | 0.130 |
Why?
|
Receptors, Ectodysplasin | 1 | 2015 | 3 | 0.130 |
Why?
|
Endemic Diseases | 1 | 2017 | 191 | 0.130 |
Why?
|
Point-of-Care Systems | 3 | 2024 | 1238 | 0.130 |
Why?
|
Ribavirin | 3 | 2014 | 395 | 0.130 |
Why?
|
Puerto Rico | 1 | 2017 | 380 | 0.130 |
Why?
|
Adolescent | 19 | 2024 | 89169 | 0.130 |
Why?
|
Murinae | 1 | 2015 | 18 | 0.130 |
Why?
|
Viral Load | 4 | 2021 | 3396 | 0.130 |
Why?
|
Immunocompromised Host | 1 | 2021 | 863 | 0.130 |
Why?
|
Antigen Presentation | 1 | 2021 | 1251 | 0.130 |
Why?
|
Rhabdoviridae | 1 | 2015 | 5 | 0.130 |
Why?
|
Intermediate Filament Proteins | 1 | 2016 | 261 | 0.120 |
Why?
|
Rhabdoviridae Infections | 1 | 2015 | 9 | 0.120 |
Why?
|
Mass Spectrometry | 1 | 2022 | 2202 | 0.120 |
Why?
|
Pregnancy Complications, Infectious | 3 | 2019 | 2185 | 0.120 |
Why?
|
Central Nervous System | 1 | 2022 | 1346 | 0.120 |
Why?
|
Flaviviridae Infections | 1 | 2014 | 7 | 0.120 |
Why?
|
GB virus C | 1 | 2014 | 9 | 0.120 |
Why?
|
Liberia | 4 | 2016 | 176 | 0.120 |
Why?
|
Hep G2 Cells | 1 | 2016 | 378 | 0.120 |
Why?
|
Asia | 2 | 2015 | 630 | 0.120 |
Why?
|
Host-Pathogen Interactions | 2 | 2020 | 1469 | 0.120 |
Why?
|
RNA | 2 | 2023 | 2722 | 0.120 |
Why?
|
Facies | 1 | 2015 | 224 | 0.120 |
Why?
|
Azithromycin | 1 | 2016 | 201 | 0.120 |
Why?
|
Semen | 1 | 2017 | 349 | 0.120 |
Why?
|
Founder Effect | 2 | 2013 | 185 | 0.120 |
Why?
|
Spondylitis, Ankylosing | 1 | 2016 | 159 | 0.120 |
Why?
|
West Nile virus | 1 | 2015 | 77 | 0.120 |
Why?
|
Dogs | 1 | 2019 | 3845 | 0.120 |
Why?
|
Glucosephosphate Dehydrogenase | 3 | 2009 | 209 | 0.120 |
Why?
|
Poliovirus | 1 | 2015 | 106 | 0.120 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 789 | 0.120 |
Why?
|
Hepatitis, Viral, Human | 1 | 2014 | 141 | 0.110 |
Why?
|
Microcephaly | 1 | 2018 | 426 | 0.110 |
Why?
|
Child, Preschool | 11 | 2024 | 42669 | 0.110 |
Why?
|
Ribosomal Proteins | 1 | 2016 | 369 | 0.110 |
Why?
|
Models, Statistical | 3 | 2016 | 5107 | 0.110 |
Why?
|
Genetic Drift | 1 | 2013 | 41 | 0.110 |
Why?
|
Fossils | 1 | 2014 | 76 | 0.110 |
Why?
|
HIV-1 | 2 | 2023 | 6963 | 0.110 |
Why?
|
Societies, Scientific | 1 | 2015 | 223 | 0.110 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 22380 | 0.110 |
Why?
|
Databases, Genetic | 2 | 2019 | 1758 | 0.110 |
Why?
|
Kinetics | 1 | 2021 | 6330 | 0.110 |
Why?
|
Pigmentation | 1 | 2014 | 143 | 0.110 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2018 | 667 | 0.110 |
Why?
|
Cross Reactions | 3 | 2021 | 828 | 0.110 |
Why?
|
Aged | 11 | 2024 | 171502 | 0.110 |
Why?
|
Primate Diseases | 1 | 2012 | 15 | 0.110 |
Why?
|
Codon | 1 | 2015 | 599 | 0.110 |
Why?
|
Geography | 3 | 2017 | 652 | 0.110 |
Why?
|
Vagina | 1 | 2019 | 850 | 0.110 |
Why?
|
Toll-Like Receptor 5 | 1 | 2013 | 42 | 0.110 |
Why?
|
Organoids | 1 | 2019 | 743 | 0.100 |
Why?
|
Genetic Vectors | 1 | 2022 | 3403 | 0.100 |
Why?
|
Brazil | 1 | 2017 | 1250 | 0.100 |
Why?
|
Receptors, LDL | 1 | 2015 | 493 | 0.100 |
Why?
|
World Health Organization | 1 | 2019 | 1328 | 0.100 |
Why?
|
Molecular Sequence Annotation | 1 | 2015 | 527 | 0.100 |
Why?
|
Dominican Republic | 1 | 2012 | 78 | 0.100 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 6231 | 0.100 |
Why?
|
Africa South of the Sahara | 2 | 2012 | 752 | 0.100 |
Why?
|
Cell Separation | 1 | 2018 | 1728 | 0.100 |
Why?
|
Flagellin | 1 | 2013 | 124 | 0.100 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1673 | 0.100 |
Why?
|
Infant | 8 | 2024 | 36535 | 0.100 |
Why?
|
Cardiology | 1 | 2023 | 1702 | 0.100 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2013 | 183 | 0.100 |
Why?
|
Massachusetts | 2 | 2021 | 8890 | 0.100 |
Why?
|
Genetic Pleiotropy | 1 | 2013 | 181 | 0.100 |
Why?
|
Mefloquine | 1 | 2011 | 55 | 0.090 |
Why?
|
Gene Knock-In Techniques | 1 | 2013 | 422 | 0.090 |
Why?
|
Cells, Cultured | 3 | 2021 | 19025 | 0.090 |
Why?
|
HIV Infections | 3 | 2023 | 17569 | 0.090 |
Why?
|
Hepatitis B virus | 1 | 2015 | 533 | 0.090 |
Why?
|
Infant, Newborn | 5 | 2024 | 26421 | 0.090 |
Why?
|
Drug Resistance, Bacterial | 2 | 2023 | 1063 | 0.090 |
Why?
|
Reproducibility of Results | 5 | 2024 | 20225 | 0.090 |
Why?
|
Renal Dialysis | 1 | 2020 | 1791 | 0.090 |
Why?
|
Phenanthrenes | 1 | 2011 | 66 | 0.090 |
Why?
|
K562 Cells | 2 | 2024 | 644 | 0.090 |
Why?
|
Glycoproteins | 2 | 2015 | 2202 | 0.090 |
Why?
|
Fluid Therapy | 1 | 2015 | 587 | 0.090 |
Why?
|
Gambia | 3 | 2011 | 104 | 0.090 |
Why?
|
Antigens | 1 | 2016 | 1443 | 0.090 |
Why?
|
Ethanolamines | 1 | 2011 | 152 | 0.090 |
Why?
|
Baseball | 1 | 2011 | 95 | 0.090 |
Why?
|
RNA Splicing | 1 | 2015 | 905 | 0.090 |
Why?
|
Malaria, Cerebral | 1 | 2012 | 136 | 0.090 |
Why?
|
Haiti | 1 | 2012 | 553 | 0.090 |
Why?
|
Specimen Handling | 1 | 2015 | 707 | 0.090 |
Why?
|
Awards and Prizes | 1 | 2015 | 365 | 0.090 |
Why?
|
Drug Resistance, Microbial | 1 | 2013 | 830 | 0.090 |
Why?
|
Severity of Illness Index | 5 | 2021 | 15949 | 0.090 |
Why?
|
Genes, Fungal | 1 | 2011 | 440 | 0.090 |
Why?
|
Research Personnel | 1 | 2015 | 589 | 0.090 |
Why?
|
Scalp | 1 | 2013 | 391 | 0.080 |
Why?
|
Fluorenes | 1 | 2011 | 160 | 0.080 |
Why?
|
Models, Molecular | 4 | 2020 | 5402 | 0.080 |
Why?
|
Parasites | 1 | 2012 | 160 | 0.080 |
Why?
|
Child | 12 | 2024 | 80917 | 0.080 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 1854 | 0.080 |
Why?
|
User-Computer Interface | 1 | 2016 | 1407 | 0.080 |
Why?
|
DNA, Intergenic | 1 | 2010 | 108 | 0.080 |
Why?
|
Cation Transport Proteins | 1 | 2012 | 326 | 0.080 |
Why?
|
Proteins | 1 | 2024 | 6009 | 0.080 |
Why?
|
Cohort Studies | 3 | 2024 | 41753 | 0.080 |
Why?
|
Cholesterol, HDL | 1 | 2015 | 1820 | 0.080 |
Why?
|
Brain Injuries | 1 | 2021 | 2057 | 0.080 |
Why?
|
Liver Transplantation | 1 | 2021 | 2401 | 0.080 |
Why?
|
Glycogen Storage Disease Type I | 1 | 2009 | 53 | 0.080 |
Why?
|
Genetics, Medical | 2 | 2014 | 334 | 0.080 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2009 | 127 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2018 | 1596 | 0.080 |
Why?
|
DNA Fingerprinting | 1 | 2008 | 114 | 0.080 |
Why?
|
Protein Structure, Tertiary | 3 | 2015 | 3772 | 0.080 |
Why?
|
Bayes Theorem | 3 | 2022 | 2359 | 0.080 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1397 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2020 | 1942 | 0.080 |
Why?
|
Food | 1 | 2013 | 768 | 0.070 |
Why?
|
Dyslipidemias | 1 | 2015 | 873 | 0.070 |
Why?
|
Multifactorial Inheritance | 2 | 2015 | 1422 | 0.070 |
Why?
|
Organ Specificity | 2 | 2024 | 1968 | 0.070 |
Why?
|
Immunoglobulin G | 4 | 2022 | 4568 | 0.070 |
Why?
|
Myocardium | 1 | 2021 | 4790 | 0.070 |
Why?
|
Genetic Association Studies | 3 | 2013 | 2744 | 0.070 |
Why?
|
Immunity | 1 | 2014 | 1003 | 0.070 |
Why?
|
Triglycerides | 1 | 2015 | 2464 | 0.070 |
Why?
|
T-Lymphocytes | 3 | 2021 | 10266 | 0.070 |
Why?
|
RNA, Untranslated | 1 | 2011 | 455 | 0.070 |
Why?
|
Codon, Nonsense | 1 | 2009 | 287 | 0.070 |
Why?
|
Publishing | 1 | 2015 | 837 | 0.070 |
Why?
|
NF-kappa B | 2 | 2013 | 2494 | 0.070 |
Why?
|
Community Health Services | 1 | 2012 | 659 | 0.070 |
Why?
|
Inflammation | 3 | 2022 | 10873 | 0.070 |
Why?
|
Anti-HIV Agents | 1 | 2023 | 4573 | 0.070 |
Why?
|
Receptors, Virus | 2 | 2021 | 651 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2014 | 1542 | 0.070 |
Why?
|
Escherichia coli | 1 | 2019 | 4213 | 0.070 |
Why?
|
Seasons | 3 | 2023 | 1524 | 0.070 |
Why?
|
Obesity | 3 | 2021 | 13091 | 0.070 |
Why?
|
Oligonucleotides | 2 | 2020 | 563 | 0.070 |
Why?
|
Gene Dosage | 1 | 2011 | 1219 | 0.070 |
Why?
|
Antiporters | 1 | 2007 | 276 | 0.070 |
Why?
|
Protein Binding | 2 | 2016 | 9343 | 0.070 |
Why?
|
Cholesterol, LDL | 1 | 2015 | 2403 | 0.060 |
Why?
|
Case-Control Studies | 8 | 2021 | 22290 | 0.060 |
Why?
|
Spinocerebellar Degenerations | 1 | 2005 | 44 | 0.060 |
Why?
|
Microarray Analysis | 1 | 2008 | 753 | 0.060 |
Why?
|
Arylamine N-Acetyltransferase | 1 | 2006 | 87 | 0.060 |
Why?
|
Kidney | 1 | 2021 | 7064 | 0.060 |
Why?
|
Population | 1 | 2006 | 141 | 0.060 |
Why?
|
Logistic Models | 2 | 2018 | 13290 | 0.060 |
Why?
|
Genetic Heterogeneity | 1 | 2009 | 736 | 0.060 |
Why?
|
Liver | 1 | 2021 | 7578 | 0.060 |
Why?
|
Tuberculosis | 2 | 2012 | 2029 | 0.060 |
Why?
|
Urethritis | 1 | 2024 | 30 | 0.060 |
Why?
|
DNA Repair | 2 | 2013 | 2050 | 0.060 |
Why?
|
Homozygote | 3 | 2007 | 1779 | 0.060 |
Why?
|
Base Composition | 2 | 2012 | 291 | 0.060 |
Why?
|
Telomere | 1 | 2011 | 943 | 0.060 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2009 | 605 | 0.060 |
Why?
|
Anti-Infective Agents | 1 | 2012 | 983 | 0.060 |
Why?
|
Major Histocompatibility Complex | 1 | 2007 | 877 | 0.060 |
Why?
|
Communicable Diseases | 1 | 2013 | 873 | 0.060 |
Why?
|
Trinucleotide Repeats | 1 | 2005 | 257 | 0.060 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2006 | 897 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12077 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2017 | 4585 | 0.060 |
Why?
|
Seizures | 1 | 2017 | 2998 | 0.060 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2005 | 432 | 0.060 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2024 | 85 | 0.060 |
Why?
|
Lactase | 1 | 2004 | 72 | 0.060 |
Why?
|
Retrospective Studies | 7 | 2024 | 81760 | 0.060 |
Why?
|
Antigens, Differentiation | 1 | 2006 | 921 | 0.060 |
Why?
|
Chiroptera | 1 | 2024 | 62 | 0.060 |
Why?
|
Aged, 80 and over | 5 | 2021 | 59626 | 0.050 |
Why?
|
Recurrence | 1 | 2016 | 8509 | 0.050 |
Why?
|
Forecasting | 1 | 2013 | 2945 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2007 | 4413 | 0.050 |
Why?
|
Antigens, CD | 2 | 2020 | 4035 | 0.050 |
Why?
|
Microsatellite Repeats | 1 | 2005 | 785 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2020 | 9262 | 0.050 |
Why?
|
Population Density | 2 | 2014 | 193 | 0.050 |
Why?
|
Research | 1 | 2011 | 1979 | 0.050 |
Why?
|
Gene Pool | 1 | 2002 | 36 | 0.050 |
Why?
|
Markov Chains | 2 | 2018 | 979 | 0.050 |
Why?
|
Caspases | 1 | 2006 | 882 | 0.050 |
Why?
|
DNA, Viral | 2 | 2021 | 2204 | 0.050 |
Why?
|
Internet | 1 | 2015 | 3110 | 0.050 |
Why?
|
Intestines | 1 | 2011 | 1909 | 0.050 |
Why?
|
Epitopes | 2 | 2021 | 2527 | 0.050 |
Why?
|
Receptors, Chemokine | 1 | 2005 | 652 | 0.050 |
Why?
|
Lung | 1 | 2021 | 10101 | 0.050 |
Why?
|
Microbial Sensitivity Tests | 2 | 2023 | 1967 | 0.050 |
Why?
|
Mycobacterium tuberculosis | 1 | 2013 | 1930 | 0.050 |
Why?
|
Time Factors | 4 | 2020 | 40220 | 0.050 |
Why?
|
Cross Protection | 1 | 2021 | 25 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18349 | 0.050 |
Why?
|
DNA Copy Number Variations | 1 | 2010 | 2048 | 0.050 |
Why?
|
Genes, Protozoan | 2 | 2012 | 170 | 0.050 |
Why?
|
Immunoglobulin M | 2 | 2018 | 1528 | 0.050 |
Why?
|
Prospective Studies | 3 | 2021 | 54924 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7951 | 0.050 |
Why?
|
Fatty Acid Desaturases | 1 | 2021 | 102 | 0.050 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2020 | 1441 | 0.050 |
Why?
|
Bioterrorism | 1 | 2022 | 144 | 0.050 |
Why?
|
Heterozygote | 2 | 2005 | 2798 | 0.050 |
Why?
|
Isoenzymes | 1 | 2006 | 1688 | 0.050 |
Why?
|
Pregnancy | 5 | 2019 | 30255 | 0.050 |
Why?
|
Pregnancy Outcome | 2 | 2019 | 2972 | 0.050 |
Why?
|
Disease Vectors | 1 | 2020 | 61 | 0.050 |
Why?
|
Biological Factors | 1 | 2022 | 156 | 0.050 |
Why?
|
Saccharomyces cerevisiae | 1 | 2011 | 2682 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9755 | 0.040 |
Why?
|
Deoxyribonuclease I | 1 | 2021 | 228 | 0.040 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2020 | 105 | 0.040 |
Why?
|
Cluster Analysis | 3 | 2015 | 2732 | 0.040 |
Why?
|
Bystander Effect | 1 | 2020 | 89 | 0.040 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2024 | 452 | 0.040 |
Why?
|
Chromosomes, Human, X | 1 | 2002 | 320 | 0.040 |
Why?
|
Hospitals, Teaching | 2 | 2017 | 1157 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2018 | 65379 | 0.040 |
Why?
|
Nasopharynx | 1 | 2023 | 420 | 0.040 |
Why?
|
GATA1 Transcription Factor | 1 | 2021 | 306 | 0.040 |
Why?
|
South Africa | 2 | 2019 | 1873 | 0.040 |
Why?
|
Principal Component Analysis | 2 | 2014 | 948 | 0.040 |
Why?
|
Immune Sera | 1 | 2020 | 605 | 0.040 |
Why?
|
Myelopoiesis | 1 | 2020 | 135 | 0.040 |
Why?
|
HLA-DQ Antigens | 1 | 2020 | 190 | 0.040 |
Why?
|
Chromosomes | 2 | 2014 | 578 | 0.040 |
Why?
|
China | 2 | 2016 | 2395 | 0.040 |
Why?
|
Atlases as Topic | 1 | 2021 | 248 | 0.040 |
Why?
|
Mice, Obese | 1 | 2020 | 418 | 0.040 |
Why?
|
Adipocytes, Brown | 1 | 2020 | 160 | 0.040 |
Why?
|
Blood Donors | 1 | 2021 | 343 | 0.040 |
Why?
|
Virus Internalization | 1 | 2023 | 503 | 0.040 |
Why?
|
Hematuria | 1 | 2020 | 232 | 0.040 |
Why?
|
Phagocytes | 1 | 2021 | 294 | 0.040 |
Why?
|
Larynx | 1 | 2024 | 492 | 0.040 |
Why?
|
Cytokines | 3 | 2021 | 7452 | 0.040 |
Why?
|
Promoter Regions, Genetic | 3 | 2009 | 5797 | 0.040 |
Why?
|
DNA | 2 | 2023 | 7213 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2021 | 348 | 0.040 |
Why?
|
Quality Control | 1 | 2021 | 836 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 325 | 0.040 |
Why?
|
New England | 1 | 2022 | 1058 | 0.040 |
Why?
|
Boston | 2 | 2023 | 9374 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 3833 | 0.040 |
Why?
|
Travel | 2 | 2017 | 805 | 0.040 |
Why?
|
Hypertrophy | 1 | 2020 | 562 | 0.040 |
Why?
|
Erythrocytes | 1 | 2008 | 2418 | 0.040 |
Why?
|
Cell Line | 2 | 2024 | 15602 | 0.040 |
Why?
|
Survivors | 2 | 2020 | 2381 | 0.040 |
Why?
|
Oligonucleotide Probes | 1 | 2019 | 417 | 0.040 |
Why?
|
Demography | 2 | 2014 | 1641 | 0.040 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2020 | 435 | 0.040 |
Why?
|
Plasmids | 1 | 2023 | 2269 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2021 | 665 | 0.040 |
Why?
|
Fluorescence | 1 | 2020 | 757 | 0.040 |
Why?
|
Gene Deletion | 1 | 2005 | 2674 | 0.040 |
Why?
|
Validation Studies as Topic | 1 | 2018 | 162 | 0.040 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2005 | 1247 | 0.040 |
Why?
|
Biological Assay | 1 | 2020 | 628 | 0.040 |
Why?
|
Templates, Genetic | 1 | 1997 | 188 | 0.040 |
Why?
|
Proteinuria | 1 | 2020 | 611 | 0.040 |
Why?
|
Tacrolimus | 1 | 2021 | 750 | 0.040 |
Why?
|
Chemokines | 1 | 2021 | 963 | 0.030 |
Why?
|
Cheirogaleidae | 1 | 2016 | 9 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2023 | 939 | 0.030 |
Why?
|
Homeostasis | 2 | 2020 | 3348 | 0.030 |
Why?
|
Regression Analysis | 2 | 2022 | 6340 | 0.030 |
Why?
|
Rodentia | 1 | 2018 | 262 | 0.030 |
Why?
|
Caribbean Region | 1 | 2017 | 193 | 0.030 |
Why?
|
Survival Analysis | 3 | 2014 | 10099 | 0.030 |
Why?
|
Interferons | 1 | 2020 | 720 | 0.030 |
Why?
|
Workflow | 1 | 2021 | 860 | 0.030 |
Why?
|
Arenavirus | 1 | 2016 | 8 | 0.030 |
Why?
|
Likelihood Functions | 1 | 2020 | 994 | 0.030 |
Why?
|
Population Dynamics | 1 | 2018 | 314 | 0.030 |
Why?
|
Pedigree | 3 | 2009 | 4539 | 0.030 |
Why?
|
Microfluidics | 1 | 2022 | 672 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2021 | 610 | 0.030 |
Why?
|
Callithrix | 1 | 2016 | 95 | 0.030 |
Why?
|
Aedes | 1 | 2017 | 101 | 0.030 |
Why?
|
Climate | 1 | 2017 | 146 | 0.030 |
Why?
|
Neoplasms | 2 | 2023 | 22371 | 0.030 |
Why?
|
Age Factors | 3 | 2021 | 18415 | 0.030 |
Why?
|
Blood Cells | 1 | 2018 | 309 | 0.030 |
Why?
|
Florida | 1 | 2017 | 417 | 0.030 |
Why?
|
Age Distribution | 1 | 2021 | 2873 | 0.030 |
Why?
|
Genetic Linkage | 2 | 2013 | 2342 | 0.030 |
Why?
|
Mali | 1 | 2015 | 51 | 0.030 |
Why?
|
Sequence Homology | 1 | 2015 | 197 | 0.030 |
Why?
|
Viral Vaccines | 1 | 2021 | 596 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 788 | 0.030 |
Why?
|
Ectoderm | 1 | 2015 | 138 | 0.030 |
Why?
|
Epitope Mapping | 1 | 2016 | 301 | 0.030 |
Why?
|
Vibrio cholerae | 2 | 2013 | 793 | 0.030 |
Why?
|
Viral Core Proteins | 1 | 2015 | 158 | 0.030 |
Why?
|
Membrane Transport Proteins | 1 | 2020 | 1037 | 0.030 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2007 | 2171 | 0.030 |
Why?
|
Democratic Republic of the Congo | 1 | 2014 | 87 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2021 | 1035 | 0.030 |
Why?
|
Chromosomes, Mammalian | 1 | 2015 | 148 | 0.030 |
Why?
|
Hospitals, Pediatric | 1 | 2024 | 1876 | 0.030 |
Why?
|
Protozoan Proteins | 1 | 2020 | 844 | 0.030 |
Why?
|
Protective Clothing | 1 | 2015 | 103 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2020 | 2065 | 0.030 |
Why?
|
Gene Conversion | 1 | 2014 | 69 | 0.030 |
Why?
|
Risk Assessment | 1 | 2016 | 24318 | 0.030 |
Why?
|
Eye Color | 1 | 2014 | 35 | 0.030 |
Why?
|
International Agencies | 1 | 2015 | 244 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2023 | 1891 | 0.030 |
Why?
|
Lactose Intolerance | 1 | 2014 | 28 | 0.030 |
Why?
|
Skeleton | 1 | 2014 | 29 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 2015 | 752 | 0.030 |
Why?
|
Genes, Viral | 1 | 2015 | 655 | 0.030 |
Why?
|
Antibody Specificity | 1 | 2016 | 1065 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 1997 | 901 | 0.030 |
Why?
|
Tibet | 1 | 2013 | 10 | 0.030 |
Why?
|
Anti-Retroviral Agents | 1 | 2023 | 1789 | 0.030 |
Why?
|
History, Ancient | 1 | 2014 | 213 | 0.030 |
Why?
|
Mongolia | 1 | 2013 | 93 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2020 | 1377 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36741 | 0.030 |
Why?
|
Rivers | 1 | 2013 | 65 | 0.030 |
Why?
|
Multilocus Sequence Typing | 1 | 2013 | 102 | 0.030 |
Why?
|
Zebrafish | 1 | 2024 | 3035 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2020 | 11677 | 0.030 |
Why?
|
England | 1 | 2014 | 533 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2016 | 1683 | 0.030 |
Why?
|
Virulence | 1 | 2016 | 1297 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2024 | 2726 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2021 | 2451 | 0.030 |
Why?
|
Protein Conformation | 1 | 2020 | 3956 | 0.030 |
Why?
|
Agriculture | 1 | 2014 | 186 | 0.030 |
Why?
|
Spain | 1 | 2014 | 485 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2020 | 1966 | 0.030 |
Why?
|
Leptin | 1 | 2020 | 1599 | 0.030 |
Why?
|
Signal Transduction | 2 | 2013 | 23648 | 0.030 |
Why?
|
Quantitative Trait, Heritable | 1 | 2015 | 540 | 0.020 |
Why?
|
Binding Sites | 2 | 2011 | 6019 | 0.020 |
Why?
|
Glycosylation | 1 | 2015 | 1100 | 0.020 |
Why?
|
Parasitic Sensitivity Tests | 1 | 2012 | 90 | 0.020 |
Why?
|
Regeneration | 1 | 2021 | 1524 | 0.020 |
Why?
|
Probability | 1 | 1997 | 2479 | 0.020 |
Why?
|
Chromatin | 1 | 2024 | 2981 | 0.020 |
Why?
|
Cytoplasm | 1 | 2016 | 1505 | 0.020 |
Why?
|
Mucins | 1 | 2015 | 570 | 0.020 |
Why?
|
Skin Pigmentation | 1 | 2014 | 280 | 0.020 |
Why?
|
Molecular Typing | 1 | 2012 | 115 | 0.020 |
Why?
|
Internationality | 1 | 2017 | 1008 | 0.020 |
Why?
|
Pseudogenes | 1 | 2011 | 104 | 0.020 |
Why?
|
Antiviral Agents | 2 | 2015 | 3072 | 0.020 |
Why?
|
Parasitemia | 1 | 2012 | 166 | 0.020 |
Why?
|
Vomiting | 1 | 2014 | 655 | 0.020 |
Why?
|
Health | 1 | 2014 | 398 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7477 | 0.020 |
Why?
|
Monocytes | 1 | 2020 | 2605 | 0.020 |
Why?
|
Genetic Testing | 1 | 2004 | 3591 | 0.020 |
Why?
|
Insect Vectors | 1 | 2011 | 136 | 0.020 |
Why?
|
DNA Polymerase beta | 1 | 2010 | 19 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2909 | 0.020 |
Why?
|
Malawi | 1 | 2012 | 312 | 0.020 |
Why?
|
Lipoproteins | 1 | 2015 | 880 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2021 | 5902 | 0.020 |
Why?
|
Carrier Proteins | 2 | 2016 | 4939 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2014 | 794 | 0.020 |
Why?
|
Fibroblasts | 1 | 2021 | 4178 | 0.020 |
Why?
|
Adiposity | 1 | 2020 | 1895 | 0.020 |
Why?
|
Gestational Age | 1 | 2019 | 3621 | 0.020 |
Why?
|
Sentinel Surveillance | 1 | 2012 | 292 | 0.020 |
Why?
|
Heterosexuality | 1 | 2012 | 309 | 0.020 |
Why?
|
Human Genome Project | 1 | 2010 | 202 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2011 | 472 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3948 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2015 | 1461 | 0.020 |
Why?
|
Nucleotides | 1 | 2012 | 455 | 0.020 |
Why?
|
Exons | 2 | 2006 | 2394 | 0.020 |
Why?
|
Endodeoxyribonucleases | 1 | 2010 | 165 | 0.020 |
Why?
|
Fetal Death | 1 | 2011 | 434 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2020 | 2907 | 0.020 |
Why?
|
Eye | 1 | 2013 | 712 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2011 | 1379 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2021 | 3703 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 4528 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 2015 | 1478 | 0.020 |
Why?
|
Pregnancy Trimester, Third | 1 | 2011 | 587 | 0.020 |
Why?
|
Glucose | 1 | 2020 | 4352 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2535 | 0.020 |
Why?
|
Virus Replication | 1 | 2016 | 2458 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6512 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3589 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4206 | 0.020 |
Why?
|
Inflammasomes | 1 | 2013 | 540 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2014 | 1070 | 0.020 |
Why?
|
Heart | 1 | 2021 | 4446 | 0.020 |
Why?
|
Diarrhea | 1 | 2014 | 1320 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1752 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3814 | 0.020 |
Why?
|
Valine | 1 | 2009 | 410 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3800 | 0.020 |
Why?
|
Incidence | 2 | 2017 | 21538 | 0.020 |
Why?
|
Central America | 1 | 2006 | 69 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5884 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4120 | 0.020 |
Why?
|
Bangladesh | 1 | 2009 | 742 | 0.020 |
Why?
|
Europe | 2 | 2005 | 3436 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2020 | 3986 | 0.020 |
Why?
|
Caspase 12 | 1 | 2006 | 8 | 0.020 |
Why?
|
Methionine | 1 | 2009 | 573 | 0.020 |
Why?
|
Cholesterol | 1 | 2015 | 2914 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2016 | 2892 | 0.020 |
Why?
|
Adaptation, Biological | 1 | 2007 | 147 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2010 | 2748 | 0.020 |
Why?
|
Disease Transmission, Infectious | 1 | 2011 | 560 | 0.020 |
Why?
|
Amygdalin | 1 | 2005 | 1 | 0.020 |
Why?
|
Arbutin | 1 | 2005 | 2 | 0.020 |
Why?
|
HLA-DR Antigens | 1 | 2007 | 609 | 0.020 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2010 | 606 | 0.020 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2006 | 313 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2016 | 3713 | 0.020 |
Why?
|
Utah | 1 | 2005 | 130 | 0.020 |
Why?
|
Codon, Terminator | 1 | 2006 | 125 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3428 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2020 | 12801 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5802 | 0.020 |
Why?
|
Benzyl Alcohols | 1 | 2005 | 33 | 0.020 |
Why?
|
Time | 1 | 2007 | 552 | 0.020 |
Why?
|
Glycosides | 1 | 2005 | 100 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10478 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15453 | 0.010 |
Why?
|
Hospitalization | 1 | 2024 | 10840 | 0.010 |
Why?
|
Homosexuality, Male | 1 | 2012 | 1344 | 0.010 |
Why?
|
Body Mass Index | 1 | 2021 | 13053 | 0.010 |
Why?
|
Antigens, Neoplasm | 1 | 2011 | 1996 | 0.010 |
Why?
|
Mortality | 1 | 2014 | 2911 | 0.010 |
Why?
|
Acetylation | 1 | 2006 | 1056 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5520 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8542 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3806 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26379 | 0.010 |
Why?
|
Genes | 1 | 2006 | 1824 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9669 | 0.010 |
Why?
|
Glucosides | 1 | 2005 | 533 | 0.010 |
Why?
|
Risk Factors | 2 | 2021 | 74944 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2015 | 14488 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 13013 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2011 | 3604 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 8080 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 3445 | 0.010 |
Why?
|
Autoimmunity | 1 | 2006 | 1361 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13668 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2011 | 7609 | 0.010 |
Why?
|
Family | 1 | 2007 | 3209 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5804 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2006 | 5505 | 0.010 |
Why?
|
Research Design | 1 | 2011 | 6209 | 0.010 |
Why?
|
Health Surveys | 1 | 2004 | 4057 | 0.010 |
Why?
|
Rural Population | 1 | 2004 | 2325 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2010 | 9617 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 11095 | 0.010 |
Why?
|
Transcription Factors | 1 | 2011 | 12171 | 0.010 |
Why?
|